1. Home
  2. VERU vs SIEB Comparison

VERU vs SIEB Comparison

Compare VERU & SIEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • SIEB
  • Stock Information
  • Founded
  • VERU 1971
  • SIEB 1886
  • Country
  • VERU United States
  • SIEB United States
  • Employees
  • VERU N/A
  • SIEB N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • SIEB Investment Bankers/Brokers/Service
  • Sector
  • VERU Health Care
  • SIEB Finance
  • Exchange
  • VERU Nasdaq
  • SIEB Nasdaq
  • Market Cap
  • VERU 108.8M
  • SIEB 94.9M
  • IPO Year
  • VERU 1990
  • SIEB N/A
  • Fundamental
  • Price
  • VERU $0.57
  • SIEB $2.70
  • Analyst Decision
  • VERU Strong Buy
  • SIEB
  • Analyst Count
  • VERU 4
  • SIEB 0
  • Target Price
  • VERU $4.00
  • SIEB N/A
  • AVG Volume (30 Days)
  • VERU 6.2M
  • SIEB 12.2K
  • Earning Date
  • VERU 02-13-2025
  • SIEB 11-12-2024
  • Dividend Yield
  • VERU N/A
  • SIEB N/A
  • EPS Growth
  • VERU N/A
  • SIEB 61.43
  • EPS
  • VERU N/A
  • SIEB 0.27
  • Revenue
  • VERU $16,886,419.00
  • SIEB $83,357,000.00
  • Revenue This Year
  • VERU N/A
  • SIEB N/A
  • Revenue Next Year
  • VERU N/A
  • SIEB N/A
  • P/E Ratio
  • VERU N/A
  • SIEB $10.03
  • Revenue Growth
  • VERU 22.46
  • SIEB 27.81
  • 52 Week Low
  • VERU $0.49
  • SIEB $1.41
  • 52 Week High
  • VERU $1.92
  • SIEB $3.34
  • Technical
  • Relative Strength Index (RSI)
  • VERU 44.48
  • SIEB 40.32
  • Support Level
  • VERU $0.49
  • SIEB $2.51
  • Resistance Level
  • VERU $0.56
  • SIEB $2.99
  • Average True Range (ATR)
  • VERU 0.05
  • SIEB 0.14
  • MACD
  • VERU 0.00
  • SIEB 0.00
  • Stochastic Oscillator
  • VERU 63.62
  • SIEB 39.58

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About SIEB Siebert Financial Corp.

Siebert Financial Corp is a holding company. It conducts retail discount brokerage business through its wholly-owned subsidiary. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.

Share on Social Networks: